Source ForPressRelease.com

ZenOnco.io, the World’s First Integrative Oncology healthtech platform, has received global recognition at the European Society for Medical Oncology (ESMO) Annual Virtual Congress on September 21, 2020 for introducing the World’s First Artificial Intelligence-based tool to generate directional cancer treatment assessment reports free of cost: ZIOPARTM (ZenOnco.io Integrative Oncology Preliminary Assessment Report). This is soon after ZenOnco.io launched India’s first online cancer community – CANNECT dedicated to connecting cancer patients, survivors, caregivers and other healthcare professionals to share their experiences and knowledge to inspire each other. Both these accomplishments have been in collaboration with its sister concern Love Heals Cancer (section 80G registered NGO).



The newly diagnosed cancer patients per clinical oncologist ratio is poor at 150+ in 76% countries of the world, which can result in a low quality of care for many cancer patients. 85% cancer patients prefer to know the possible treatment options. ZIOPARTM provides Artificial Intelligence-based directional cancer treatment assessment reports free of cost to patients to guide them on possible treatment options, covering both medical as well as complementary treatment approaches. Cancer patients are required to provide six basic inputs that determine the output of the report (detailed up to 20-25 pages), with information on medical treatment options, diagnostic tests required, and complementary treatment approaches (including guidelines on nutrition, fitness, stress-management, and symptom management). ZIOPARTM is based on standard protocols, guidelines and research by esteemed organizations in oncology, such as ESMO, Society of Integrative Oncology (SIO), National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), and others.



ZIOPARTM has already benefitted 21,000+ cancer patients and caregivers across 16 countries by providing detailed directional cancer treatment assessment reports. ZIOPARTM is free to use to empower and educate millions of cancer patients in knowing their possible treatment options, asking the right questions to their doctors, and being confident in their treatment.



CANNECT is another free platform introduced by ZenOnco.io to make quality integrative cancer care accessible to all. It connects cancer patients, survivors, caregivers and other healthcare professionals to share their experiences and knowledge to inspire each other.



Kishan Shah, Co-founder of ZenOnco.io and Love Heals Cancer, says “Being recognised globally at the ESMO Annual Virtual Congress 2020 is a testimony to our dedication to making quality integrative cancer care accessible to all.



ZIOPARTM is the result of countless months of efforts puts in by oncologists, scientists, technology team and feedback from patients. It empowers cancer patients to ask the right questions to ensure that they are on the right treatment path. We have already helped 21,000+ cancer patients through ZIOPARTM, but there is still a huge scope to help millions of more cancer patients. We are also very proud to launch India’s first cancer community – CANNECT to bring together thousands of cancer warriors.”



Dimple Parmar, Co-founder of ZenOnco.io and Love Heals Cancer, adds “ZIOPARTM is an advanced tool based on Artificial Intelligence and protocols issued by international bodies. The purpose of the tool is to educate and empower cancer patients to know their indicative treatment plan on both medical as well as complementary treatment fronts. Along with guidance on treatment, we have also been receiving requests from thousands of cancer patients that they want to connect with other cancer warriors who have either gone through a similar cancer journey or are going through it. CANNECT brings together all cancer warriors so that they can connect with, learn from and inspire each other. Because we heal together in a community.”